Rural Health
News by Topic: Infectious diseases

HRSA: Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Payment Reporting Activities, OMB No. 0906-0068-Revision Federal Register

Jun 26, 2025 - Notice from the Health Resources and Services Administration (HRSA) seeking comments on an information collection regarding a form related to the COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) rural payment reporting activities. The information collection is used to assess if statutory and programmatic requirements are met; conduct audits; report on findings with respect to the disbursements of PRF and ARP Rural payments; and for the program evaluation. Comments are due by August 25, 2025.

view details

CDC: Proposed Data Collection Submitted for Public Comment and Recommendations Federal Register

Jun 16, 2025 - The Centers for Disease Control and Prevention (CDC) is seeking comments on a proposed information collection project titled "National Healthcare Safety Network (NHSN) Respiratory Data." This information collection is designed to standardize the data elements collected from across the country regarding the impact of respiratory viruses on healthcare facilities. Comments are due by August 15, 2025.

view details

CDC: Solicitation of Nominations for Appointment to the Advisory Committee to the Director Federal Register

Jun 16, 2025 - The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the Advisory Committee to the Director (ACD). The ACD consists of up to 15 experts knowledgeable in areas pertinent to the CDC mission, including public health, infectious disease, data science and Artificial Intelligence (AI), global health, public health preparedness, and related fields. Nominations are due by July 16, 2025.

view details

FDA: Revocation of Four Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability Federal Register

May 29, 2025 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Pfizer Inc., MAWD Laboratories, and Nuclein, LLC (merged with Molecular Diagnostics Inc.) related to COVID-19 detection and diagnosis tests.

view details